Clinical trial · Aging · Added 25 Sept 2026
Rumo zhentong Yin for blood-stasis-type osteoporotic pain: protocol of a randomized, single-blind, controlled trial
Source: Frontiers in Aging
What the research found
BackgroundOsteoporosis (OP) is a metabolic skeletal disease characterized by reduced bone mass and micro-architectural deterioration, with Osteoporotic pain (OPP) as its most common clinical symptom, which markedly impairs quality of life. Modern pharmacologic treatments’ limitations are obvious with population aging, so the cost-effective interventions for OPP are urgently needed. As an empirical formula, Rumo zhent
Evidence level: Clinical trial. This is among the stronger kinds of evidence, but one study rarely settles a question.
More aging news
- In middle-aged male mice, an earlier loss of new tumor-fighting immune cells lined up with weaker melanoma control
- A commentary says telomere RNA loops can stall DNA copying and, in some tumors, get used to keep chromosome ends going
- After a long decline, heart-valve death rates in U.S. older adults rose from 2018 to 2023
- In adults over 50 followed for 24 years, a higher body mass index lined up with a faster drop in memory and thinking
- A lab force on bone extended lifespan in older mice through a signal called PEDF